Hitachi Healthcare Americas Partners with the WVU Heart and Vascular Institute to Advance the Evaluation of Left Ventricular Mechanical Function

Published on:

Hitachi Healthcare and the West Virginia University Heart and Vascular Institute today announced the formation of a new partnership to advance the evaluation of left ventricle (LV) mechanical function using advanced analysis tools that can provide a more comprehensive assessment of cardiovascular disease. Partho Sengupta, M.D., the Heart and Vascular Institute’s director of cardiovascular imaging, will serve as the project’s principal investigator during this multi-year strategic partnership. 

The goal of the partnership is to provide evidence that cardiac multidimensional imaging with assessment of fluid mechanics has important roles in predicting non-invasive parameters in the study of percutaneous valve interventions. Vector flow mapping (VFM) is an echocardiographic technology from Hitachi Healthcare that is capable of evaluating the instantaneous blood motion in the LV.

VFM is able to quantify the formation of vortices, quantify dissipative energy loss caused by turbulence, as well as better quantify gradients and regurgitation associated with heart valves and vascular structures. By using VFM analysis during structural heart interventions such as transcatheter aortic valve replacement (TAVR) and mitraclip devices, the hope is to optimize and develop an individualized approach and better outcomes for structural heart interventions.
 
“In an era when percutaneous interventions have evolved to provide excellent therapeutic options for patients, cardiac flow mechanics has the distinct opportunity of going above and beyond traditional echocardiographic techniques in optimizing structural heart techniques,” Dr. Sengupta said.

The Lisendo 880, along with Hitachi’s VFM technology, was developed around the most important needs for cardiovascular diagnosis. “By creating a clinical partnership with the West Virginia University Heart and Vascular Institute and Dr. Sengupta, Hitachi Healthcare is taking an important step in finding advancements in clinical care for our cardiovascular patients,” John Waddell, Vice President, General Manager Ultrasound of Hitachi Healthcare Americas, said.

Related Content

Concomitant ablation surgery during heart operations boosts long-term survival
Cardiologist explores why colchicine failed to help heart attack patients
Bioresorbable BTK stent superior to ballon angioplasty at 2 years
Most heart failure patients miss out on guideline-recommended palliative care
Cardiologist behind EARLY TAVR explains how proactive treatment improves patient outcomes
FDA approves Medtronic’s new all-in-one mapping and ablation system for AFib

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."